Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension

Published:2020-10 Issue:4 Volume:10 Page:1-8
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Verlinden Nathan J.¹^ORCID,Benza Raymond L.²,Raina Amresh¹

Affiliation:

1. Cardiovascular InstituteAllegheny General HospitalPittsburghPAUSA

2. Division of Cardiovascular MedicineThe Ohio State University Wexner Medical CenterColumbusOHUSA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894020945523

Reference22 articles.

1. Pulmonary arterial hypertension;Farber HW;N Engl J Med,2004

2. An evaluation of long‐term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry;Benza RL;Chest,2012

3. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galie N;Eur Heart J,2016

4. Therapy for pulmonary arterial hypertension in adults: Update of the CHEST guideline and expert panel report;Klinger JR;Chest,2019

5. Pathways and drugs in pulmonary arterial hypertension ‐ Focus on the role of endothelin receptor antagonists;Madonna R;Cardiovasc Drugs Ther,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo assessment, formulation, characterization and enhancing pharmacotherapy of encapsulated mini tablets for immediate release Sildenafil citrate and sustained release Bosentan;Results in Chemistry;2024-07

2. Comprehensive Update on Synthetic Aspects of Bosentan Derivatives;Mini-Reviews in Medicinal Chemistry;2022-05-10

3. Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT);Pulmonary Circulation;2022-04

4. The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study;Frontiers in Pharmacology;2022-01-12